The results showed that TIMP1 was enriched in pathways including allograft rejection, glycosphingolipid biosynthesis ganglion series, citric acid cycle recycling, and Parkinson's disease (Figure 5e). This evidence concerns the gene TIMP1 and Parkinson disease.